Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 7/20 | 1.00 |
| ▸ | CA12 | O43570 | 5/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 5/20 | 0.73 |
| ▸ | CA2 | P00918 | 3/20 | 0.73 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.68 |
| ▸ | POLB | P06746 | 2/20 | 0.68 |
| ▸ | RECQL | P46063 | 2/20 | 0.68 |
| ▸ | CASP6 | P55212 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | APEX1 | P27695 | 1/20 | 0.68 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | PPARA | Q07869 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | PDE6D | O43924 | 1/20 | 0.54 |
| ▸ | CA4 | P22748 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20735193 | 0.86 | ALDH1A1 (0.82) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL3841868 | 0.86 | L3MBTL1 (0.75) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL28166422 | 0.86 | CA9 (0.75) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL16589414 | 0.86 | CA9 (0.75) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL31663432 | 0.84 | CA9 (1.00) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL481667 | 0.84 | CA9 (1.00) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL10061703 | 0.84 | CA9 (0.73) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL1514286 | 0.84 | L3MBTL1 (0.73) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL16601986 | 0.83 | CA9 (0.77) | CA9CA12L3MBTL1RXFP1CA1 | |
| SCHEMBL299841 | 0.83 | ALDH1A1 (0.71) | CA9CA12L3MBTL1RXFP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070123514-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-05-31 | — | — | US | claimed |
| WO-2007030939-A2 | METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-03-22 | — | — | WO | claimed |
| EP-3049387-B1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & CO (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3049387-B1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & CO (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3049387-A1 | THERMOPLASTIC POLYMER COMPOSITION | Milliken & Company (US) | 2016-08-03 | — | — | EP | disclosed |
| EP-3049468-A1 | THERMOPLASTIC POLYMER COMPOSITION | Milliken & Company (US) | 2016-08-03 | — | — | EP | disclosed |
| EP-3049388-A1 | THERMOPLASTIC POLYMER COMPOSITION | Milliken & Company (US) | 2016-08-03 | — | — | EP | disclosed |
| EP-3049469-A1 | THERMOPLASTIC POLYMER COMPOSITION | Milliken & Company (US) | 2016-08-03 | — | — | EP | disclosed |
| US-9200144-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-9200144-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| US-9200142-B2 | Thermoplastic polymer composition | MILLIKEN & COMPANY (US) | 2015-12-01 | — | — | US | disclosed |
| WO-2015042563-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY (US) | 2015-03-26 | — | — | WO | disclosed |
| US-8501046-B2 | Use of rylene derivatives as photosensitizers in solar cells | BASF SE (DE) | 2013-08-06 | — | — | US | disclosed |
| US-20120283432-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | MAX-PLANCK-GESEL. ZUR FOERDERUNG DER WISSEN. E.V. (DE) | 2012-11-08 | — | — | US | disclosed |
| US-8231809-B2 | Solid p-semiconductors may also be used in the inventive dye-sensitized solar cells without increasing the cell resistance, since the rylene derivatives absorb strongly and therefore require only thin n-semiconductor layers | BASF AKTIENGESELLSCHAFT (DE) | 2012-07-31 | — | — | US | disclosed |
| US-20080269482-A1 | Use of Rylene Derivatives as Photosensitizers in Solar Cells | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| US-20070123514-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-05-31 | — | — | US | disclosed |
| US-20070123514-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-05-31 | — | — | US | disclosed |
| US-20070123514-A1 | Methods of modulating neurotrophin-mediated activity | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-05-31 | — | — | US | disclosed |
| WO-2007030939-A2 | METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY | PAINCEPTOR PHARMA CORPORATION (CA) | 2007-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283432-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | NR2E3, NR2E1, NR1D2 | CA9 3076/4885CA12 2135/4885L3MBTL1 2444/4885 |
| US-20070123514-A1 | Methods of modulating neurotrophin-mediated activity | NGF, BDNF, NTRK2 | CA9 3754/4885CA12 1700/4885L3MBTL1 4441/4885 |
| US-20080269482-A1 | Use of Rylene Derivatives as Photosensitizers in Solar Cells | NR2E3, NR2E1, NR1D2 | CA9 3139/4885CA12 2183/4885L3MBTL1 2559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.